[1]
“Gauging the Antiobesity Potential of Oral Semaglutide in Type 2 Diabetes in the Indian Context”, IJCP, vol. 33, no. 11, pp. 8–12, Apr. 2023, Accessed: Apr. 03, 2025. [Online]. Available: https://ojs.ijcp.in/index.php/IJCP/article/view/147